Answers are grounded in this paper and cite their sources.
The metal–organic framework CPO-27-Ni is presented as a proof-of-concept model for the incorporation and release of two non-conventional anticancer drugs: [Ru(p-cymene)Cl2(pta)] (RAPTA-C) and NO.
No takes yet. Share an insight, caveat, or question.
Rojas et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: